CAR‑T therapies could break through in this year’s commercial‑insurance price talksChina Finance Tech in ChinaCAR-T, Healthcare, Heyuan Shengwu, Medical Insurance, National Healthcare Security Administration, Pharmaceuticals November 4, 2025
CAR‑T therapies: “Sky‑high” CAR‑T Cancer Therapies Could Break Through in This Year’s Commercial‑Insurance Price NegotiationsChina Finance China StartupsCailian Press, Healthcare, Heyuan Shengwu, NHSA, Pharmaceuticals November 3, 2025
